"Designing Growth Strategies is in our DNA"
In the fiscal year of 2018, Fate Therapeutics, one of the experts in induced pluripotent stem cells collaborated with ONO Pharmaceutical Co. Ltd., for the commercialization of two off-the-shelf product candidates related to CAR-T cell. The use of stem cell therapy, as regenerative medicines, has received a huge upsurge as they pose fewer complications and considered a permanent treatment option.
Induced pluripotent stem cells are a type of artificially derived pluripotent stem cells by inducing certain genes. Induced pluripotent stem cells are generated by the introduction of a certain set of specific genes having pluripotency-associated genes into a mature somatic cell. Induced pluripotent stem cells have created new avenues in clinical research, regenerative medicines, and disease modeling. This has also paved the way to numerous mergers and acquisitions and potential pipeline products and patents.
To gain extensive insights into the market, Request for Customization
The growth in global induced pluripotent stem cells market is being driven by the active government support through research grants, increased private funding, and shift towards regenerative medicines. In addition, the diversity of donor candidates and increased accessibility to the cell of origin are also factors that are likely to fuel the global induced pluripotent stem cells market in the anticipated years.
However, ethical issues related to the donors, potential risk of tumors are some of the factors that are projected to restrict the growth of global induced pluripotent stem cells market.
Some of the major companies that are present in the global induced pluripotent stem cells market are Astellas Pharma Inc., Ncardia, Applied StemCell, FUJIFILM Cellular Dynamics Inc., Axol Bioscience Ltd., Bristol-Myers Squibb Company, R&D Systems Inc., Fate Therapeutics, Evotec AG, ViaCyte Inc., and other players.
By Derived Cell Type
· Amniotic cells
· Regenerative medicines
· Drug development
· Toxicity testing
· Reprogramming technology
· Academic research
· Education & research institutes
· Biotechnological companies
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
As of 2018, the regenerative medicines segment is estimated to dominate the global induced pluripotent stem cells market owing to the rise in demand for induced pluripotent stem cells mediated regenerative medicines.
The global induced pluripotent stem cells market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to register a fast growth in induced pluripotent stem cells market in the forecast years owing to the huge investment by private players for research and potential pipeline products. In Europe, the induced pluripotent stem cells market is projected to expand by the end of 2026, due to the active government support and new product launches. In 2018, Ncardia, a company working for drug discovery using stem cell, launched Xpress.4U LightPace Cor.4U, a kit for improving and simplifying the use of optical pacing of cardiomyocytes, a human induced pluripotent stem cell, which expected to favor the induced pluripotent stem cells market in Europe.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry